Reply to 'Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review'

K Lee¹, Y-R Chung¹

Affiliations

Comment

K Lee et al. Eye (Lond). 2015 Jul.

. 2015 Jul;29(7):978.

doi: 10.1038/eye.2015.5. Epub 2015 Feb 27.

K Lee¹, Y-R Chung¹

¹ Department of Ophthalmology, Ajou University School of Medicine, Suwon, Republic of Korea.

No abstract available

Comment on

Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review.
Chung YR, Seo EJ, Lew HM, Lee KH. Chung YR, et al. Eye (Lond). 2013 Dec;27(12):1339-46. doi: 10.1038/eye.2013.236. Epub 2013 Nov 8. Eye (Lond). 2013. PMID: 24202051 Free PMC article. Review.
Methodological remarks concerning the recent meta-analysis on the effect of intravitral bevacizumab in central serous chorioretinopathy.
Sergentanis TN, Chatziralli IP. Sergentanis TN, et al. Eye (Lond). 2015 Jul;29(7):978. doi: 10.1038/eye.2015.8. Epub 2015 Feb 27. Eye (Lond). 2015. PMID: 25721516 Free PMC article. No abstract available.

1. Chung YR, Seo EJ, Lew HM, Lee KH. Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review. Eye. 2013;27:1339–1346. - PMC - PubMed